摘要:
PCT No. PCT/JP92/00894 Sec. 371 Date Jan. 24, 1994 Sec. 102(e) Date Jan. 24, 1994 PCT Filed Jul. 14, 1992 PCT Pub. No. WO93/02203 PCT Pub. Date Feb. 4, 1993.A new FR901451 substance which is produced by culturing a FR901451 substance-producing strain of the genus Flexibacter in a nutrient medium, this new substance possessing a human leukocyte elastase-inhibiting activity.
摘要:
A process for producing cyclosporin A and/or C by culturing a cyclosporin A and/or C producing bacterium belonging to the genus Nectria, e.g. Nectria sp. F-4908, in a medium and isolating cyclosporin A and/or C thus produced from the medium.
摘要:
An inhibitor for blood vessel hypertrophy containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient and having an excellent drug efficacy.
摘要:
This invention relates to new quinolylbenzofuran derivatives having activities as leukotrien and Slow Reacting Substance of Anaphylaxis antagonists and inhibitors and represented by general formula (I), wherein R1 is halogen, etc., R2 is hydrogen or halogen, R3 is hydrogen, halogen, hydroxy, lower alkyl or lower alkoxy, R4 is hydrogen, acyl, cyano, nitro, substituted or unsubstituted aryl, or substituted or unsubstituted lower alkyl, R5 is hydrogen, hydroxy, lower alkyl or lower alkoxy, A is lower alkylene, lower alkenylene or a single bond, X is a single bond, O, NH, S, SO or SO¿2?, and Y is O or S, provided that when R?3¿ is hydrogen, R4 is hydrogen, R5 is hydrogen, A is a single bond and X is a single bond, then R1 is halogen, etc., and pharmaceutically acceptable salts thereof, to processes for the preparation thereof and to a pharmaceutical composition comprising the same.
摘要:
An expression vector containing both of a DNA coding for L-sorbose dehydrogenase and a DNA coding for L-sorbosone dehydrogenase; a transformant capable of producing 2-keto-L-gulonic acid (2KLGA) from D-sorbitol in a high yield and prepared by transforming with the above vector a microorganism which produces L-sorbose from D-sorbitol in a high yield and which has no or little activity of decomposing 2KLGA, or such a microorganism which has, in addition, no or little activity of producing L-idonic acid; and a process for producing 2KLGA by culturing the transformant in a medium containing D-sorbitol. The invention process enables 2KLGA useful for producing L-ascorbic acid to be produced readily in a large amount at a good efficiency by single culture.
摘要:
This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc. and represented by general formula (I), wherein R1 is aryl optionally substituted with lower alkyl, etc., R2 is lower alkyl, etc., R3 is hydrogen, etc., R4 is aryl, etc., X is CH or N, and Y is CH or N, and pharmaceutically acceptable salts thereof, to processes for the preparation thereof and to a pharmaceutical composition comprising the same.